NASDAQ: GPCR · Biotechnology
Over the past week, Structure Therapeutics (GPCR) pulled in 17 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 44% bullish but is deeply split: News runs 100% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 15 of 16 analysts rating GPCR a buy.
There is little buzz around GPCR this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 94% buy share sits next to a crowd that ranges from Reddit at 0% to News at 100%. No other tracker puts the two side by side.
Across 16 analysts the consensus is a Strong Buy: 15 buy calls against 0 sell, with an average 12-month price target of $104.77.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 50 points above the crowd average of 44%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while Reddit sits at 0%, a 100-point spread that single-source trackers miss.
Over the 30-day window, Structure Therapeutics (GPCR) buzz held subdued around 35.4 while the price drifted down 10.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 683K shares. Over the last 7 trading days, GPCR lost 3.8%. Buzz activity in the recent week averaged 34.9 and was relatively stable, swinging between 30.2 and 37.7. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 11 of the 16 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for GPCR and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live GPCR sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 04, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (15 / 1 / 0) |
| Crowd bullish (7d) | 44% |
| Avg price target | $104.77 |
| Most bullish source | News, 100% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 100 pts |
| Mentions (7d) | 17 |
| Market cap | $3.38B |
| EPS · Beta | -$3.01 · -1.5 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Structure Therapeutics (GPCR) currently carries an Adanos hold signal with 65/100 conviction. The current cross-source average reads 44% bullish across 3 active sources. Those sources contribute 17 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Structure Therapeutics (GPCR) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 1 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Structure Therapeutics (GPCR), averaging 44% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 100% bullish and Reddit at 0%, a 100-point spread. On the professional side, 15 of 16 analysts rate GPCR a buy.
Of the 16 analysts covering Structure Therapeutics (GPCR), 15 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $104.77. That puts the street ahead of the crowd, which averages 44% bullish.
Structure Therapeutics (GPCR)'s cross-source average is bearish at 44% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. X reads 33% bullish, News reads 100% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad mixed pressure with 65/100 conviction.
The cross-source average is bearish for Structure Therapeutics (GPCR) at 44% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling on News, while x activity is rising. The hold signal carries 65/100 conviction.
X is the dominant discussion channel with 12 mentions (71% of total volume). News contributes 5 mentions. The cross-source average is bearish at 44% bullish, while x is the only source with rising 3-day activity. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. GPCR's hold signal at 65/100 conviction reflects a bearish cross-source average at 44% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The GPCR sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key